每经AI快讯,有投资者在投资者互动平台提问:请问公司与美国梯瓦制药战略合作发展进展如何?是否已经盈利模式? 复星医药(600196.SH)11月14日在投资者互动平台表示,截至目前,公司与美国梯瓦就在研药物TEV-56278的开发合作如期推进,相关药物于许可区域内尚处临床前阶段。如有后续重大进展,公司将根据上市地规则要求进行披露。(文章来源:每日经济新闻)
Source Link每经AI快讯,有投资者在投资者互动平台提问:请问公司与美国梯瓦制药战略合作发展进展如何?是否已经盈利模式? 复星医药(600196.SH)11月14日在投资者互动平台表示,截至目前,公司与美国梯瓦就在研药物TEV-56278的开发合作如期推进,相关药物于许可区域内尚处临床前阶段。如有后续重大进展,公司将根据上市地规则要求进行披露。(文章来源:每日经济新闻)
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.